LB Pharmaceuticals appoints new chief financial officer
LB Pharmaceuticals appointed Joseph Miller as chief financial officer.
Miller previously served as CFO of Aurinia Pharmaceuticals, overseeing the buildout of finance operations through the commercial launch of LUPKYNIS.
He also held CFO, principal executive officer, and corporate secretary roles at Avalo Therapeutics, leading acquisitions and a divestiture of its commercial portfolio.
LBRX•
